Femasys Inc.

Contributing Author

Recent Articles by Femasys Inc.

Nov-14	Femasys Announces Third Quarter Financial Results for 2025 FEMY +8.58% GlobeNewswire
Nov-10	Femasys Advances Global Growth with Second Partner Order for FemBloc in Europe FEMY GlobeNewswire
Nov-03	Femasys Secures FDA Approval to Advance Final FemBloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million FEMY GlobeNewswire
Oct-22	Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc Permanent Birth Control in Europe FEMY GlobeNewswire
Oct-16	Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo FEMY GlobeNewswire
Sep-25	Femasys Accelerates European Growth for FemBloc with Kebomed Partnership FEMY GlobeNewswire
Sep-22	Femasys Partners with Medical Electronic Systems to Launch FemSperm Analysis Kit for use with FemaSeed FEMY GlobeNewswire
Sep-11	Femasys Expands FemSperm Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed FEMY GlobeNewswire
Sep-08	Femasys Secures Regulatory Approval for FemBloc Permanent Birth Control in New Zealand FEMY GlobeNewswire
Sep-02	Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios FEMY GlobeNewswire
Aug-25	Femasys Announces Pricing of $8.0 Million Underwritten Public Offering FEMY GlobeNewswire
Aug-21	Femasys Announces FemSperm Kit to Activate Gynecologists and Advance FemaSeed Fertility Platform FEMY GlobeNewswire
Aug-20	Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control FEMY GlobeNewswire
Aug-08	Femasys Announces Second Quarter Financial Results for 2025 FEMY GlobeNewswire
Aug-06	Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion FEMY GlobeNewswire
Jul-01	Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed for First-Line Infertility Treatment and FemVue Diagnostic FEMY GlobeNewswire
Jun-25	Femasys Announces Historic Milestone with European Approval of FemBloc, the First Non-Surgical Permanent Birth Control FEMY GlobeNewswire
Jun-17	Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth FEMY GlobeNewswire
Jun-11	Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed in its More than 8 Locations FEMY GlobeNewswire
May-30	Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million FEMY GlobeNewswire
May-29	Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement FEMY GlobeNewswire
May-08	Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update FEMY GlobeNewswire

Femasys Inc.

Recent Articles by Femasys Inc.

Upgrade your FINVIZ experience